Acme Generics Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Acme Generics Private Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $7.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Acme Generics Private Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $7.1M Trade | TransData Nexus

Acme Generics Private Limited

Indian Pharmaceutical Exporter · Diabetes & Endocrine Specialist · $7.1M Total Trade · DGFT Verified

Acme Generics Private Limited is an Indian pharmaceutical exporter with a total trade value of $7.1M across 6 products in 5 therapeutic categories. Based on 285 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Levothyroxine ($3.4M), Acetaminophen ($1.1M), Loperamide ($910.9K).

Acme Generics Private Limited — Export Portfolio & Destination Treemap

Acme Generics Private Limited pharmaceutical export portfolio — 6 products across 5 therapeutic categories. Source: Indian Customs (DGFT).

Who is Acme Generics Private Limited? — Company Overview & Market Position

Acme Generics Private Limited is a privately held pharmaceutical company based in Mohali, Punjab, India. Established on July 30, 2021, the company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The Corporate Identification Number (CIN) assigned to Acme Generics is U24100PB2021PTC056566. As of March 2026, the company reports an authorized capital of ₹121.44 crore and a paid-up capital of ₹120.10 crore. The registered office is located at Plot No. 132, 2nd Floor, Sector 82, JLPL, Mohali, Punjab, 140308.

Acme Generics has demonstrated significant growth since its inception, with a total export value of $7.1 million USD and 285 shipments across six products in five therapeutic categories. The company's product portfolio is notably concentrated, with the top five products accounting for 93.6% of total exports. This concentration underscores the company's strategic focus on specific high-demand pharmaceutical formulations.

What Does Acme Generics Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Levothyroxine$3.4M

Product Portfolio — Top 6 by Export Value

Acme Generics Private Limited exports 6 pharmaceutical products across 5 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Levothyroxine	Diabetes & Endocrine	$3.4M	190	4.4%	6
2	Acetaminophen	Analgesics & Antipyretics	$1.1M	21	0.5%	15
3	Loperamide	Gastrointestinal	$910.9K	31	1.2%	12
4	Salicylic	Combination Drugs	$686.1K	19	4.1%	7
5	Mycophenolate	Immunosuppressants	$612.4K	14	0.2%	12
6	Acetylsalicylic	Combination Drugs	$450.9K	10	10.3%	2

Acme Generics Private Limited exports 6 pharmaceutical products across 5 therapeutic categories with a total export value of $7.1M. The top category is Diabetes & Endocrine (47.7% of portfolio), followed by Combination Drugs (16.0%), indicating a concentrated portfolio with the top 5 products accounting for 93.6% of total export value.

Acme Generics Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Acme Generics operates state-of-the-art manufacturing facilities designed to produce a diverse range of pharmaceutical products. The company's manufacturing plant is strategically located in Baddi, Himachal Pradesh, a region known for its pharmaceutical manufacturing infrastructure. The facility boasts an annual production capacity of 60 million general liquid and lyophilized vials, 60 million liquid and lyophilized vials for oncology, 30 million three-piece ophthalmic containers, and 24 million pre-filled syringes and cartridges. This expansive capacity enables Acme Generics to meet both domestic and international demand effectively.

3Key Leadership

The leadership team at Acme Generics Private Limited comprises experienced professionals committed to steering the company towards its strategic objectives. Viral Shah serves as the Director, bringing a wealth of experience in pharmaceutical operations and strategic management. Vikas Sharma holds the position of Whole-Time Director, overseeing day-to-day operations and ensuring the alignment of manufacturing processes with regulatory standards. Ginny Uppal serves as the Company Secretary, responsible for ensuring compliance with corporate governance norms and facilitating effective communication between the board of directors and stakeholders.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Acme Generics Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Acme Generics has established a robust presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has been audited and approved by various international regulatory agencies, including the US FDA, UK MHRA, EU GMP, Health Canada, TGA Australia, ANVISA, INVIMA, and WHO Geneva. These approvals underscore Acme Generics' commitment to maintaining high-quality manufacturing standards and its capability to meet the stringent requirements of these markets. The company has received approvals across major emerging markets in Asia, Africa, CIS, and Latin America, further expanding its global footprint.

2Emerging Markets

Acme Generics has strategically penetrated emerging markets in Africa, Latin America, and Southeast Asia. The company's adherence to WHO prequalification standards has facilitated access to these regions, enabling it to supply essential medicines to underserved populations. By aligning its manufacturing processes with WHO guidelines, Acme Generics ensures the safety, efficacy, and quality of its products, thereby enhancing its reputation and market share in these emerging markets.

3Geographic Strategy

Acme Generics Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Acme Generics has achieved significant milestones in the U.S. market, with 38 Abbreviated New Drug Applications (ANDAs) approved and 18 ANDAs filed and under review. The company's manufacturing facility has been audited and approved by the U.S. Food and Drug Administration (FDA), affirming its compliance with stringent U.S. regulatory standards. This approval not only facilitates the marketing of Acme Generics' products in the U.S. but also enhances the company's credibility in other regulated markets.

2WHO & EU GMP

Acme Generics has obtained Good Manufacturing Practice (GMP) certifications from the World Health Organization (WHO) and the European Union (EU). These certifications validate the company's commitment to maintaining high-quality manufacturing standards and its capability to produce pharmaceutical products that meet international quality benchmarks. The EU GMP certification, in particular, opens avenues for the company to market its products across EU member states, thereby expanding its reach in the European market.

3CDSCO & Indian Regulatory

Acme Generics Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Acme Generics operates in a competitive landscape with several key players in the pharmaceutical manufacturing sector. While specific market share data is not publicly available, the company's focus on high-demand products such as Levothyroxine, Acetaminophen, Loperamide, Salicylic, and Mycophenolate positions it favorably in the market. The company's adherence to international quality standards and its strategic focus on both regulated and emerging markets enhance its competitive edge.

2Key Differentiators

Acme Generics' key differentiators include its specialized expertise in oral hormones, particularly female sex hormones and Levothyroxine, as well as its capabilities in liquid and lyophilized injectables. The company's substantial manufacturing capacity, including the production of 60 million general liquid and lyophilized vials annually, underscores its ability to meet large-scale demand. Additionally, Acme Generics' global regulatory approvals and certifications from agencies such as the FDA, WHO, and EU GMP highlight its commitment to quality and compliance.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Acme Generics Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Acme Generics has demonstrated a strong track record in pharmaceutical manufacturing, with a total export value of $7.1 million USD and 285 shipments across six products in five therapeutic categories. The company's manufacturing facility in Baddi, Himachal Pradesh, is equipped with substantial production capacity, enabling it to meet both domestic and international demand effectively. The absence of adverse regulatory actions and the company's adherence to international quality standards further attest to its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm the company's FDA registration status and approved ANDAs through the FDA's official database.

WHO-GMP Certification: Verify the WHO-GMP certification by consulting the WHO's official list of prequalified manufacturers.

Frequently Asked Questions — Acme Generics Private Limited

How many pharmaceutical products does Acme Generics Private Limited export from India?

Acme Generics Private Limited exports 6 pharmaceutical products across 5 therapeutic categories. The top exports are Levothyroxine ($3.4M), Acetaminophen ($1.1M), Loperamide ($910.9K), Salicylic ($686.1K), Mycophenolate ($612.4K). Total export value is $7.1M.

What is Acme Generics Private Limited's total pharmaceutical export value?

Acme Generics Private Limited's total pharmaceutical export value is $7.1M, based on 285 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Acme Generics Private Limited cover?

Acme Generics Private Limited exports across 5 therapeutic categories. The largest are Diabetes & Endocrine (47.7%, 1 products), Combination Drugs (16.0%, 2 products), Analgesics & Antipyretics (14.8%, 1 products).

Get Full Acme Generics Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.